Rchr
J-GLOBAL ID：201901005631592969   Update date: Jun. 17, 2024

Okada Naoko

オカダ ナオコ | Okada Naoko
Research theme for competitive and other funds  (4)：
  • 2022 - 2025 エピジェネティクスを基盤としたアレルギー疾患における難治化機序の解明
  • 2022 - 2025 COVID-19の長期後遺症に関わるEBウイルス再活性化制御因子の探索
  • 2021 - 2024 難治性慢性副鼻腔炎における病原性線維芽細胞の制御による新規治療法の開発
  • 2019 - 2022 Elucidation of the onset mechanism of chronic fatigue mediated by herpes virus and search for its regulator
Papers (61)：
  • Hiroshi Fujishima, Hiroyuki Yazu, Eisuke Shimizu, Naoko Okada, Kazumi Fukagawa. Eye Washing Downregulated Angiotensin-Converting Enzyme 2 in Conjunctival Tissue Samples from Smokers. International Journal of Molecular Sciences. 2023
  • 岡田 直子, 矢津 啓之, 清水 映輔, 深川 和己, 布村 聡, 斎藤 博久, 松本 健治, 川口 淳, 出原 賢治, 藤島 浩. 眼アレルギー研究と臨床の進歩 重症アレルギー性結膜炎におけるタクロリムス点眼薬の治療応答性予測法の探索. アレルギー. 2023. 72. 6-7. 884-884
  • Kenichiro Motomura, Hideaki Morita, Naoko Okada, Akio Matsuda, Susumu Nakae, Mikiya Fujieda, Haruhiko Sago, Hirohisa Saito, Kenji Matsumoto. Comprehensive Analysis of the Expression and Functions of Pattern Recognition Receptors in Differentiated Cytotrophoblasts Derived from Term Human Placentas. Journal of immunology (Baltimore, Md. : 1950). 2023. 210. 10. 1552-1563
  • Naoko Okada, Hiroyuki Yazu, Eisuke Shimizu, Kazumi Fukagawa, Satoshi Nunomura, Hirohisa Saito, Kenji Matsumoto, Atsushi Kawaguchi, Kenji Izuhara, Hiroshi Fujishima. Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis. Allergy. 2022. 78. 1. 319-321
  • Satoshi Nunomura, Isao Kitajima, Yasuhiro Nanri, Midori Kitajima, Naoko Ejiri, I-Shuan Lai, Naoko Okada, Kenji Izuhara. The FADS mouse: A novel mouse model of atopic keratoconjunctivitis. The Journal of allergy and clinical immunology. 2021. 148. 6. 1596-1602
ｍore...
MISC (69)：
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM